Ixabepilone is an epothilone B analog developed by Bristol-Myers Squibb as a
chemotherapeutic medication for cancer. It is produced by Sorangium cellulosum
Learn about IXEMPRA® (ixabepilone), including safety and boxed warning, side
effects, benefits and risks, and dosing information.
Ixabepilone is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug.
Ixabepilone is classified as an "antimicrotubule agent" or an "epothilone B ...
Generic Name: Ixabepilone Ixempra is the trade name for the generic
chemotherapy drug Ixabepilone. In some cases, health care professionals may
use the ...
Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus
Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With
IXEMPRA Kit (ixabepilone) for Injection, for intravenous infusion only. Initial U.S.
... DILUENT. The ixabepilone concentration in constituted solution is 2 mg/mL.
Ixabepilone Injection: learn about side effects, dosage, special precautions, and
more on MedlinePlus.
Learn about Ixempra (Ixabepilone) may treat, uses, dosage, side effects, drug
interactions, warnings, patient labeling, reviews, and related medications.
Pharmacokinetic studies with ixabepilone given on a daily dosing schedule have
demonstrated a rapid 1-log decline after drug infusion, later followed by a ...
Ixabepilone is an orally bioavailable semisynthetic analogue of epothilone B with
antineoplastic activity. Ixabepilone binds to tubulin and promotes tubulin ...